Abiopharma

Clinical trial NCT07316608 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-29 → 2026-06-05 3. primary completion date: 2026-05-29 → 2026-06-05

Clinical trial NCT07164170 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-10-25 → 2025-09-22

Clinical trial NCT07514286 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-03 3. completion date: 2026-12-01 → 2027-02-01 4. primary completion date: 2026-12-01 → 2027-02-01

Clinical trial NCT07582042 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-06-15

Clinical trial NCT07379645 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-05-11 3. primary completion date: 2026-05-01 → 2026-05-11 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04023591 updates: 1. completion date: 2026-12-01 → 2030-12-01 2. primary completion date: 2026-03-01 → 2030-03-01

Clinical trial NCT07504601: start date: 2026-06-21 → 2026-06-22.

Clinical trial NCT07219238: start date: 2026-05-01 → 2026-10-01.

Clinical trial NCT03213041 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2023-07-01 → 2022-03-30 3. primary completion date: 2022-06-01 → 2021-06-01 4. enrollment: 100 → 12 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05029999 updates: 1. completion date: 2026-04-20 → 2029-04-20 2. primary completion date: 2026-04-20 → 2028-04-20 3. collaborators added: National Cancer Institute (NCI) 4. collaborators removed: National Institutes of Health (NIH)